Gastroesophageal Reflux Disease Therapeutics Market Heartburn Relief on the Rise Expanding Gastroesophageal Reflux Disease Therapeutics

Gastroesophageal Reflux Disease Therapeutics Market to reach over USD 6.06 billion by the year 2031 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-kinetic agents)- Market Outlook And Industry Analysis 2031"

The global Gastroesophageal Reflux Disease Therapeutics market is estimated to reach over USD 6.06 billion by 2031, exhibiting a CAGR of 1.58% during the forecast period.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1705

GERD on the Rise: Propelling the Growth of the Gastroesophageal Reflux Disease Market
The market for gastroesophageal reflux disease (GERD) treatment is projected for significant growth due to several factors:
• Lifestyle and Awareness: Changing lifestyles, coupled with a growing awareness of GERD, are fueling market expansion. Approximately 20% of the population in Western cultures suffers from GERD, a chronic condition characterized by stomach acid refluxing into the esophagus. This rising awareness is expected to lead to earlier diagnosis and treatment.

• Increasing Prevalence: The overall prevalence of gastric reflux disorders is on the rise. This widespread issue among the target demographic is expected to fuel market growth as more people seek treatment.

• Industry Advancements: Development initiatives by industry players, including new product launches, acquisitions, mergers, and investments, are accelerating market expansion. The opening of specialized centers like the Medical City Frisco Heartburn and Reflux Center, offering minimally invasive procedures for GERD, exemplifies this trend.

These advancements offer patients more treatment options and are expected to drive future market growth.
Overall, the convergence of rising GERD prevalence, increased public awareness, and advancements in treatment options is creating a strong outlook for the gastroesophageal reflux disease market.

List of Prominent Players in the Gastroesophageal Reflux Disease Therapeutics Market:
• AstraZeneca;
• Aurobindo Pharma Limited
• Cadila Pharmaceuticals Limited
• Camber Pharmaceuticals Inc.
• CHEPLAPHARM Arzneimittel GmbH
• Daewoong Pharmaceutical Co., Ltd
• Eisai Co. Ltd.
• EndoStim, Inc.
• GlaxoSmithKline PLC
• Ironwood Pharmaceuticals, Inc.;
• Jeil Pharmaceutical Co., Ltd.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Phathom Pharmaceuticals Inc.
• Reckitt Benckiser Group PLC
• Sebela Pharmaceuticals
• SFJ Pharmaceuticals Group
• SRS Life Sciences Pte. Ltd.
• Sun Pharmaceutical Industries Limited
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceuticals Industries Limited

Market Dynamics:
Drivers-
TIF (transoral incisionless fundoplication) is used to treat GERD. TIF can lead to a shorter treatment period, less pain, and a quicker recovery than laparoscopic surgery. Using a specific TIF device, a path is created for an endoscope, a flexible, tube-like imaging instrument. Using preloaded tweezers and fasteners, the procedure enables the doctor to fix or replace the valve,

a natural barrier to reflux. Clinical trials are currently being carried out to evaluate the effectiveness of endoscopic therapy for GERD. To strengthen the anti-reflux barrier, stitches are inserted into the stomach using an endoscopic sewing machine. As a result of the previous comments, the market is anticipated to lead throughout the forecast period.

Challenges:
Even though everything is working in the market's favour, there are certain inescapable limitations, including patient mortality and a lackluster treatment pipeline. Due to the abundance of treatments available on the market for treating symptoms, there is the fierce rivalry.

Regional Trends:
North America is expected to expand and take the lead throughout the projection period. The United States is leading the market among other nations in the region because of things like rising healthcare spending, expanding research and technological advancements, and rising rates of gastroesophageal reflux disease (GERD). Moreover, the main factor driving the US GERD market is the growing elderly population across the nation.

A surgical procedure named a laparoscopic Nissen fundoplication is used to treat GERD. With GERD becoming more common, surgery is becoming more necessary. GERD is a widespread disorder affecting many people today, albeit more prevalent in western nations, particularly the United States.

According to a Nissen Fundoplication article that appeared in the National Library of Medicine in July 2022, GERD is the condition with the highest prevalence in the country, affecting 18.1% to 27.8% of people. Given the disease's significant prevalence there, it is expected that the presence and development of cutting-edge and potent medications will be necessary for the nation. Driving the nation's market growth in the process.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1705

Recent Developments:
• In June 2022, The Food and Drug Administration (FDA) permitted Zydus Lifesciences to market Famotidine tablets in strengths of 20mg and 40mg. Famotidine is a histamine H2 receptor blocker that functions by reducing stomach acid. The medication also prevents and treats heartburn and other acid indigestion symptoms.

Segmentation of Gastroesophageal Reflux Disease Therapeutics Market-
By Drug Type-
• Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)
• Pro-kinetic agents

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/gastroesophageal-reflux-disease-therapeutics-market/1705

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.